Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 126,932,693 10.100% | 7,971,487 (+6.70%) | Filing History |
| 2022-02-17 2:43 pm Purchase | 2022-02-15 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 375,947 12.900% | 166,667 (+79.64%) | Filing History |
| 2022-02-17 2:11 pm Unchanged | 2021-12-31 | 13G | Agenus Inc. AGEN | GILEAD SCIENCES INC. GILD | 566,111 4.300% | 0 (Unchanged) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Gilead Sciences, Inc. GILD | Capital Research Global Investors | 107,156,981 8.500% | -14,515,418 (-11.93%) | Filing History |
| 2022-02-10 4:55 pm Purchase | 2021-12-31 | 13G | Sierra Oncology, Inc. SRRA | GILEAD SCIENCES INC. GILD | 1,450,566 9.200% | 377,266 (+35.15%) | Filing History |
| 2022-02-10 4:51 pm Sale | 2021-04-20 | 13G | Allogene Therapeutics, Inc. ALLO | GILEAD SCIENCES INC. GILD | 1,156,689 0.800% | -6,330,000 (-84.55%) | Filing History |
| 2022-02-10 4:50 pm Unchanged | 2021-12-31 | 13G | Agenus Inc. AGEN | GILEAD SCIENCES INC. GILD | 566,111 4.300% | 0 (Unchanged) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Gilead Sciences, Inc. GILD | The Vanguard Group | 105,803,799 8.430% | 3,016,782 (+2.93%) | Filing History |
| 2022-02-01 5:14 pm Purchase | 2021-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 118,961,206 9.500% | 7,777,872 (+7.00%) | Filing History |
| 2021-09-10 12:17 pm Purchase | 2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX | GILEAD SCIENCES INC. GILD | 4,854,443 5.500% | 4,854,443 (New Position) | Filing History |